Skip to main content
Equibles

T3 Companies, LLC

Position in OGI — Organigram Global Inc.

CIK 2052441 NEW YORK, NY
Back to OGI Full portfolio

Position in OGI

as of Mar 31, 2026 · filed May 7, 2026
Position Value
$0
+$0 QoQ
Shares Held
0
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2025
2 quarters on record

Derivatives in OGI

reported options exposure · as of Mar 31, 2026
CallValue
$1,110
CallShares
10,000
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

T3 Companies, LLC holds $7,960,424 across 5 Drug Manufacturers - Specialty & Generic names.

# Ticker Company Shares Value (USD) Open
1 LQDA
Liquidia Corp
 87,800 $7,000,294
2 NBIX
Neurocrine Biosciences Inc
 2,000 $337,080
3
82,500 $260,700
4 HROW
Harrow, Inc.
 5,000 $212,350
5 BCRX
Biocryst Pharmaceuticals Inc
 15,000 $150,000

All Filings in OGI

Export CSV
2 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $1,110 10,000
2025-12-31 $3,765 15,200